Presented by Gaudenz Silberschmidt, Director, Policy and Strategic Directions during the 62nd session of the WHO Regional Committee for the Eastern Mediterranean
Kuwait, 5–8 October 2015
Tracking climate-related finance in Zambia, Mr. David Kaluba, National Climate Change Secretariat, Ministry of Finance, Zambia (joining by video conference)
Tracking climate-related finance in Zambia, Mr. David Kaluba, National Climate Change Secretariat, Ministry of Finance, Zambia (joining by video conference)
Tracking international climate-related finance in Viet Nam, Ms. Nguyen Thi Dieu Trinh, Department of Science, Education, Natural Resources and Environment, Ministry of Planning and Investment, Viet Nam
India's Climate Finance Resource Assessment Exercise : Rio Markers and other Tracking Tools, Mr. Appukuttan Nair Damodaran, Indian Institute of Management Bangalore, India
This presentation was made by Brigida SOARES, Timor Leste, at the 13th Annual Meeting of OECD-Asian Senior Budget Officials held in Bangkok, Thailand, on 14-15 December 2017
Reporting on desertification finance under the UNCCD (Mr. Philippe Saner and Mr. Matthias Haeni, University of Zurich on behalf of the Global Mechanism Secretariat)
Presented by Imre Hollo, Director, Division of Administration and Finance, WHO Regional Office for Europe at the 64th session of the WHO Regional Committee for Europe, on 15 September 2014.
Learning from emerging approaches - Benjamin DEQUIEDT, FranceOECD Governance
This presentation was made by Benjamin Dequiedt, Ministry for an Ecological and Solidary Transition, France, at the 1st Workshop on Green Budgeting held at the OECD, Paris, on 20 June 2018
EU budget focused on results initiative - Marco Carnaccini, ECOECD Governance
This presentation was made by Marco Carnaccini, EC, at the 12th Annual Meeting on Performance and Results held at the OECD, Paris, on 24-25 November 2016
Long-term fiscal sustainability... -- Sandra Batten, United KingdomOECD Governance
This presentation was made by Sandra Batten, United Kingdom, at the Introductory Workshop on Green Budgeting Tools held at the OECD, Paris, on 29 April 2019
This presentation was made by Lourenço Pinto, Timor-Leste, at the 14th OECD-Asian Senior Budget Officials Meeting held in Bangkok, Thailand, on 13-14 December 2018
Increasing Domestic Investment in AIDS, Tuberculosis and Malaria: Global Fund...theglobalfight
Increasing Domestic Investment in AIDS, Tuberculosis and Malaria: Global Fund Resource Mobilization in Implementing Countries
Among other things, we discuss:
-New Global Fund policies that promote implementing country investments
-Financing leveraged to date and expectations for additional increases
-On-the-ground examples of domestic resource mobilization
Tracking international climate-related finance in Viet Nam, Ms. Nguyen Thi Dieu Trinh, Department of Science, Education, Natural Resources and Environment, Ministry of Planning and Investment, Viet Nam
India's Climate Finance Resource Assessment Exercise : Rio Markers and other Tracking Tools, Mr. Appukuttan Nair Damodaran, Indian Institute of Management Bangalore, India
This presentation was made by Brigida SOARES, Timor Leste, at the 13th Annual Meeting of OECD-Asian Senior Budget Officials held in Bangkok, Thailand, on 14-15 December 2017
Reporting on desertification finance under the UNCCD (Mr. Philippe Saner and Mr. Matthias Haeni, University of Zurich on behalf of the Global Mechanism Secretariat)
Presented by Imre Hollo, Director, Division of Administration and Finance, WHO Regional Office for Europe at the 64th session of the WHO Regional Committee for Europe, on 15 September 2014.
Learning from emerging approaches - Benjamin DEQUIEDT, FranceOECD Governance
This presentation was made by Benjamin Dequiedt, Ministry for an Ecological and Solidary Transition, France, at the 1st Workshop on Green Budgeting held at the OECD, Paris, on 20 June 2018
EU budget focused on results initiative - Marco Carnaccini, ECOECD Governance
This presentation was made by Marco Carnaccini, EC, at the 12th Annual Meeting on Performance and Results held at the OECD, Paris, on 24-25 November 2016
Long-term fiscal sustainability... -- Sandra Batten, United KingdomOECD Governance
This presentation was made by Sandra Batten, United Kingdom, at the Introductory Workshop on Green Budgeting Tools held at the OECD, Paris, on 29 April 2019
This presentation was made by Lourenço Pinto, Timor-Leste, at the 14th OECD-Asian Senior Budget Officials Meeting held in Bangkok, Thailand, on 13-14 December 2018
Increasing Domestic Investment in AIDS, Tuberculosis and Malaria: Global Fund...theglobalfight
Increasing Domestic Investment in AIDS, Tuberculosis and Malaria: Global Fund Resource Mobilization in Implementing Countries
Among other things, we discuss:
-New Global Fund policies that promote implementing country investments
-Financing leveraged to date and expectations for additional increases
-On-the-ground examples of domestic resource mobilization
This presentation was delivered during the 6th Meeting of the OECD Southeast Asia Regional Programme’s Regional Policy Network on Sustainable Infrastructure, which took place on 25-26 April 2022 in Manila, the Philippines. The OECD’s Public Governance Directorate and Environment Directorate teamed up with the OECD Korea Policy Centre to organise the event. The National Economic and Development Authority (NEDA) of the Philippines co-chaired the event alongside the United States, and the Public Private Partnership Centre of the Philippines graciously provided the venue. For more details about the meeting, including the agenda and a short summary record, please visit: https://www.oecd.org/site/sipa/events/sipa-searp-philippines-2022.htm.
Presentation delivered by Mr Imre Holl, Director, Planning Resource Coordination and Performance Monitoring, WHO, at the 67th session of the WHO Regional Committee for Europe
Sustainable FP Financing and Agenda 2030 : Emerging Approaches and ToolsJoachim Chijide
Presentation made by Dr Joachim Chijide on Sustainable Family Planning Financing and Agenda 2030 : Emerging Approaches and Tools at the 2nd Sexual and Reproductive Health Community of Practice (SeRHCoP) Webinar, 23rd September 2021
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, on 14 September 2015, at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Financing the 2030 Agenda for Sustainable Development Goals (SDGs) in BangladeshMostafa Amir Sabbih
This digital artifact is prepared as per the third week final project submission requirement of 'Financing for Development: Billions to Trillions to Action' course.
Resolutions and decisions of regional interest adopted by the Seventy-sixth World Health Assembly and the Executive Board at its 152nd and 153rd sessions
Resolutions and decisions of regional interest adopted by the Seventy-fifth World Health Assembly and the Executive Board at its 150th and 151st sessions
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. WHO Financing Dialogue
Agenda item 5(d)
62nd Session of the WHO Regional
Committee for the Eastern Mediterranean
58 October 2015, Kuwait
1
2. Background of WHO financing reform:
Financial flows of development assistance for health
WHO’s overall budget
compared to overall
international financing on
development assistance for
health has decreased
(23% in 1990 to 8% in 2013)
WHO should not compete
on overall budget size
WHO Financing Dialogue
2
3. WHO budget from 1990 to 2017
• AC stable
• AC / total budget decreased
from 46% in 1990 to 21% in
201617
WHO Financing Dialogue
3
4. WHO Programme Budget 20162017
AC
(US$ million)
VC
(US$ million)
Total
(US$ million)
Categories 1 to 6 (Base) 929 2265.3 3194.3*
Outbreak and crisis
response, polio, TDR,
research in human
reproduction**
1190.6 1190.6*
Total PB 20162017 4384.9*
* US$ 236.6 million increase compared to 20142015
** Dynamic budget ceiling, event driven or decision of respective governance mechanisms and may
increase accordingly
Contingency fund 100 100
WHO Financing Dialogue
4
5. Programme Budget 20162017
by categories
765
339.9
381.7
594.5
379.7
733.5
986.1
204.5
0
200
400
600
800
1000
1200
1 ‒
Communicable
diseases
2 ‒
Noncommunicable
diseases
3 ‒ Promoting
health through the
life-course
4 ‒ Health
systems
5 ‒ Preparedness,
surveillance and
response
6 ‒ Corporate
services / enabling
functions
Other - Polio,
Tropical disease
research and
Research in
human
reproduction
Outbreak and
crisis response
WHO Financing Dialogue
5
7. -1000000
-500000
0
500000
1000000
1500000
2000000
2500000
3000000
3500000
4000000
2014-15 2016-17 2018-19
Base budget funding 20142019
as of 31 August 2015
2014-15 2016-17 2018-19
Funding
Shortfall/(Surplus)
502,069 1,689,949
Projections 203039.495* 38,285 12,335
Voluntary Contributions ** 2,429,626 547,363 44,275
Assessed Contributions ** 918,703 918,703 918,703
Approved Budget**** 3,049,300 3,194,300
* Projections as at 30 April 2015
** In the process of being partially re-mapped to 2016-17 where it
belongs
***Assessed Contributions are projected at 2014-15 levels.
****Approved Budget 2014-15 includes HRP and TDR of US$91.6 minion
WHO Financing Dialogue
7
8. Programme Budget available funding as at 31
August 2015 (%)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
%UtilizationofapprovedPB
Programme areas
% of Funds Avail.
WHO Financing Dialogue
8
9. Progress in implementing principles
since the first dialogue
Since 2013 the World Health Assembly approves the Programme Budget in its
entirety (AC+VC):
Objective to fully fund this Programme Budget
• Alignment and flexibility has improved due to strategic allocation of flexible
resources, while alignment and flexibility of contributions have not changed much
• Level of predictability at the start of the biennium has improved: 70% at the
start of the biennium 2014–2015, compared with 62% for 2012–2013 and 52% for
2010–2011.
• Transparency has increased through the Programme Budget web portal
• Expanding the contributor base is a long-term process and some small
positive signs
WHO Financing Dialogue
9
10. Meeting objectives
Financing Dialogue 2015
• Highlight WHO’s role in contributing to the
SDGs, including transition from the MDGs
• Examine progress and future plans on key
priority areas such as emergency reform and
coordinated resource mobilization
• Review progress towards full funding of the
20162017 Programme Budget and improving
the dialogue’s principles
WHO Financing Dialogue
10
11. Broadening contributor base of WHO
• WHO used to receive 80% of funding from only 20
contributors, leading to vulnerability
• Starting to broaden the base, also thanks to
countries of the Region
• A major study on broadening the contributor base
has just been concluded
• We are happy to engage further with countries and
foundations to explore possibilities
WHO Financing Dialogue
11
12. WHO Programme Budget web portal
• Provides transparency on WHO budget,
funding and financial flows
• Revised version launched in September
2015 (beta version)
• To be further revised in October 2015
• Visit:
http://extranet.who.int/programmebudget/
WHO Financing Dialogue
12
13. Welcome to the WHO Financing
Dialogue, 56 November 2015 in Geneva
• We invite high level participation from
Member States and contributors
• Announcements of contributions can be
made before, during or after the meeting,
but are not a condition for participation
• Jointly we can put WHO on a solid funding
basis to better health!
WHO Financing Dialogue
13
Editor's Notes
Programmatic focus in 2016-2017
Global health security, preparedness, surveillance and humanitarian response in emergencies: Category 5
Resilient, integrated health systems: Category 4
Scale-up of prevention and control interventions of noncommunicable diseases Category 2
Unfinished agenda of the Millennium Development Goals as well as anticipated agenda of UHC: Categories 1,3 and 5
Emerging priorities, including antimicrobial resistance, hepatitis, ageing and health, health and environment
Key:
HIV – HIV/AIDS
TUB – Tuberculosis
MAL – Malaria
NTD – Neglected Tropical Diseases
VPD – Vaccine Preventable Diseases
NCD – Noncommunicable Diseases
MNH – Mental Health and Substance Abuse
VIJ – Violence and Injuries
DHR – Disabilities and Rehabilitation
NUT – Nutrition
RHR – Reproductive, Maternal, Newborn, Child and Adolescent Health
AGE – Ageing and Health
GER – Gender, Equity and Human Rights Mainstreaming
SDH – Social Determinants of Health
PHE – Health and the Environment
NHP – National Health Policies, Strategies and Plans
IPH – Integrated People-Centred Health Services
AMT – Access to Medicines
IER – Health Systems Information and Evidence
ARC – Alert and Response Capacities
EPD – Epidemic and Pandemic-Prone Diseases
ERC – Emergency Risk and Crisis Management
FOS – Food and Safety
Alignment & Flexibility
Alignment of funding with the Programme budget 2014–2015 has improved. At the end of 2014, categories 1 to 5 were financed to at least 75% of the approved programme budget level, whereas at the same point in the previous biennium several strategic objectives had greater funding gaps
A slight improvement in the level of flexibility of funding thanks to a change in policy on the part of three donors that are now providing more core voluntary contributions
The Secretariat will further refine its internal management of funding and strategic allocation of flexible funding, with the aim of achieving overall full alignment of funding with the programme budget.
Predictability
The level of predictability at the start of the biennium has improved: 70% at the start of the biennium 2014–2015, compared with 62% for 2012–2013 and 52% for 2010–2011.
Transparency
The introduction of the programme budget web portal has significantly increased the transparency of WHO’s funding situation and its needs by programme area and major office.
Reducing vulnerability
Expanding the contributor base is a long-term process, which has only shown very limited progress so far. Despite the efforts to expand WHO’s contributor base, the Organization continues to depend on just 20 contributors (11 of them non-State actors) for 80% of its voluntary contributions. A study on broadening and deepening the contributor basis is currently being finalized and will inform the forthcoming financing dialogue.